Expression of LGR5, FZD7, TROY, and MIST1 in Perioperatively Treated Gastric Carcinomas and Correlation with Therapy Response

Figure 1

LGR5 expression in neoadjuvant-/perioperative-treated primary tumors. Ascending intensity of LGR5 expression in tumor cells (a–d). LGR5 is also expressed in desmoplastic stroma (e), in myocytes (f), in healthy mucosa cells (g), in endothelial cells (h), and in fat cell membranes (i). Original magnifications: 400-fold.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)